Anzeige
Mehr »
Login
Mittwoch, 15.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Löst diese riesige Entdeckung die Kupferkrise der KI? So ändert sich die Rechnung durch diesen Explorer!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
233 Leser
Artikel bewerten:
(1)

Glue42 Leads the Desktop Interop Movement After Stellar 2022

Finanznachrichten News

Glue42 outperforms its revenue projections for 2022 and establishes itself as the vendor of choice for simplified desktop integration solutions for buy-side and sell-side institutions of all sizes.

NEW YORK, March 3, 2023 /PRNewswire/ -- Glue42, the company that delivers seamless desktop experiences to financial institutions globally, delivered a stellar performance in 2022, exceeding projections with a record 400 percent year-on-year revenue growth.


Desktop interoperability - the ability to integrate different applications on the desktop and blur the boundaries between them to create a seamless experience for users (Straight-Through Workflows) - has been the holy grail for financial institutions for some time. The COVID-19 pandemic accelerated this demand as banks, brokers, and asset managers saw the benefits of integrating trading applications together, and today's hybrid work environment has only fueled this growth.

In 2022, Glue42 continued to fulfill the market demand for desktop interoperability and enjoyed explosive license revenue growth within major financial institutions and FinTechs that support them. The company also added a record number of new clients, from fixed income and equities, operations, wealth management, retail banking, and pensions. These included AllianceBernstein, Broadridge, Numis, and others, in addition to repeat business from existing clients.

"Glue42 prioritizes partnerships and operates with a level of integrity and passion that drives success," said a senior developer at a tier 1 global bank.

"We've hit an inflection point in the market," said James Wooster, COO of Glue42. "Large financial institutions are now aware that they don't have to install clunky interop containers when getting their apps to work together. Glue42 not only invented the concept of zero-install desktop integration but is also ideally placed to take advantage of the increasing use of Progressive Web Applications (PWAs)."

The impressive growth of Glue42, in addition to its long list of interop innovations, has also attracted a number of new partners to its network in 2022, including Symphony, Singletrack, ChatterQuant and more.

This spectacular growth has called for many new hires, including business domain experts, UX designers and software engineers, who have been instrumental in advancing the Glue42 product roadmap and building domain-specific solutions. Glue42 has also further strengthened its client and partner success functions to support its growing client base and vendor ecosystem.

James Wooster points to the release of Glue42 Server in 2022 as one of the reasons for the firm's continued success. "Glue42 Server is a unique platform that enables our customers to implement projects more quickly than ever before. They no longer need to create the back-end infrastructure services to manage application permissioning, workspaces, layouts, user behavior metrics, and notification groups. This is now available out-of-the-box."

This sentiment was echoed by many clients that attended the company's inaugural client forum in New York which is set to return later this year in London and New York.

"The Glue42 Client forum has been extremely useful to connect with industry thought leaders and share stories and best practices to raise our standards for the future," said a UX director at an Investment Bank.

And the company has no intention of slowing down, as 2023 is set to be another record-breaking year for Glue42. With expectations to accelerate its pace within greenfield territory, fiscal 2023 will see the largest-ever increase in investment in the business, including a record rise in marketing spending. Glue42 will also sponsor and participate in a selection of events in Asia-Pacific to support its growth plans there.

From a product perspective, in H1 2023, Glue42 will release three new products and will continue to update the company's two main products regularly, Glue42 Enterprise and Glue42 Core+, based on client feedback and iterations.

Most recently, Glue42 received further recognition for its product by winning the A-Team's TradingTech Insight Award for Best Smart Trader Desktop Environment for the second consecutive year.

Note to editors:
Straight-Through Workflows is a trademark of Glue42 AB.

About Glue42:
Glue42 is an award-winning desktop integration platform that provides a one-stop shop for building best-of-breed integrated desktop experiences for tier-one financial institutions globally.

Glue42's mission is to blur the boundaries between applications and create seamless desktop experiences for end-users by allowing the creation of cross-application workflows and workspaces, app stores, centralized notifications, global searching and more on financial desktops regardless of the underlying technology. The company is based in London, New York, and Sofia.

https://glue42.com/why-glue42/

Contact on behalf of Glue42
RISE-
Email: Glue42@risethrough.com

Logo - https://mma.prnewswire.com/media/872802/Glue42_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/glue42-leads-the-desktop-interop-movement-after-stellar-2022-301761648.html

© 2023 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.